2013
DOI: 10.1055/s-0032-1328687
|View full text |Cite
|
Sign up to set email alerts
|

Screening for Cervical Cancer - Minimise Risks - Maximise Benefits. Need for Adaptation in Germany in Light of the European Guidelines and Their Objectives

Abstract: !The national cancer plan calls for adjustment of the early detection scheme for cervical cancer to the quality requirements of the "European guidelines for quality assurance in cervical cancer screening". The existing scheme should be further developed and carried out in an organized, population-based framework. The objective is to lower the incidence and mortality of cervical cancer while minimising the risks and optimising the benefits of the scheme. The self-determined choice of the patients should be resp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…One important aspect of quality reports is that all hospitals are represented within the same framework, irrespective of whether they are primary or tertiary care facilities. Hospitals offering the same levels of care (primary, secondary, tertiary) can be compared to one another [1][2][3]. The disadvantage of the quality reports is that they focus on quantitative aspects.…”
Section: Zusammenfassung !mentioning
confidence: 99%
“…One important aspect of quality reports is that all hospitals are represented within the same framework, irrespective of whether they are primary or tertiary care facilities. Hospitals offering the same levels of care (primary, secondary, tertiary) can be compared to one another [1][2][3]. The disadvantage of the quality reports is that they focus on quantitative aspects.…”
Section: Zusammenfassung !mentioning
confidence: 99%
“…For the occurrence of cervical cancer a prior infection with a high-risk subtype of human papilloma virus (HPV) is necessary [3]. Since March 2007 vaccination against the HPV subtypes 16 and 18 is recommended in Germany for females aged between 12 and 17 years [4]. The early detection of cervical cancer has been a component of guidelines for cancer screening for many years and should now be further developed into an organised screening programme [5].…”
mentioning
confidence: 99%